首页> 外文期刊>Diabetes >Resistance to Insulin's Acute Direct Hepatic Effect in Suppressing Steady-State Glucose Production in Individuals With Type 2 Diabetes
【24h】

Resistance to Insulin's Acute Direct Hepatic Effect in Suppressing Steady-State Glucose Production in Individuals With Type 2 Diabetes

机译:抑制2型糖尿病患者对稳态葡萄糖产生的胰岛素急性直接肝效应的抗性

获取原文
获取原文并翻译 | 示例
       

摘要

We and others have shown that insulin acutely suppresses glucose production in fasting nondiabetic humans and dogs, by both a direct hepatic effect and an indirect (extrahepatic) effect, and in diabetic dogs by an indirect effect alone. In type 2 diabetes, there is resistance to insulin's ability to suppress hepatic glucose production, but it has not previously been determined whether the resistance is primarily at the level of the hepatocyte or the peripheral tissues. To determine whether the diabetic state reduces the direct effect of insulin in humans, we studied nine patients with untreated type 2 diabetes who underwent three studies each, 4-6 weeks apart. 1) Portal study (POR): intravenous tolbutamide was infused for 3 h with calculation of pancreatic insulin secretion from peripheral plasma C-peptide. 2) Peripheral study (PER): equidose insulin was infused by peripheral vein.3) Half- dose peripheral insulin study (1/2 PER): matched periph- eral insulin levels with study 1.
机译:我们和其他人已经表明,在空腹的非糖尿病人和狗中,胰岛素通过直接的肝作用和间接的(肝硬化)作用而急性地抑制葡萄糖的产生,而在糖尿病的狗中,仅通过间接作用就可以抑制葡萄糖的产生。在2型糖尿病中,对胰岛素抑制肝葡萄糖生成的能力有抗药性,但以前尚未确定抗药性主要是在肝细胞还是在外周组织中。为了确定糖尿病状态是否会降低胰岛素对人类的直接作用,我们研究了9位未经治疗的2型糖尿病患者,每位患者分别进行了3项研究,间隔4-6周。 1)门禁研究(POR):静脉注射甲苯磺丁酰胺3 h,计算外周血浆C肽分泌的胰腺胰岛素。 2)外周研究(PER):等剂量胰岛素经外周静脉输注。3)半剂量外周胰岛素研究(1/2 PER):将外周胰岛素水平与研究1相匹配。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号